cisapride



cisapride

O N 2 H Cl O N H N O F O

SMILES COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC
InChIKey DCSUBABJRXZOMT-UHFFFAOYSA-N

Chemical Properties

Hydrogen bond acceptors 6
Hydrogen bond donors 2
Rotatable bonds 9
Molecular weight (Da) 465.2

Database connections

Ligand site mutations 5-HT4

Bioactivities

cisapride

O N 2 H Cl O N H N O F O

Drug properties

Molecular type Small molecule
Physiological/Surrogate Surrogate
Approved drug Yes

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections

Ligand site mutations 5-HT4

Compound is not listed as a drug.